Enhanced Investments - Financial Portal

General information

Country: UNITED STATES

Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company"s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.

Website: abbott.com

Bad financial results growth rate -4.8% (average between last period year over year growth for revenue and EBITDA), there is slowdown compared to average historical growth rates (12.2%)
Dividend yield for the last twelve months 2.0%
Free cash flow yield -1.1% (LTM)
Share price is 16.1% higher than minimum and 26.0% lower than maximum for the last 3 years
The company is undervalued by EV / LTM EBITDA multiple compared to target level (20.2x vs
)
Fundamental value created in LTM (estimate)
For the last 3 months insiders sold company shares on $4.5 mln (-0.002% of cap.)

Key Financials (Download financials)

Ticker: ABT

Share price, USD: (0.0%)104.7503

year average price 106.51

year start price 109.84 2023-05-15

min close price 90.19 2023-10-12

max close price 120.96 2024-03-08

current price 104.74 2024-05-13

Common stocks: 1 746 881 140

Dividend Yield: 2.0%

FCF Yield LTM: -1.1%

EV / LTM EBITDA: 20.2x

EV / EBITDA annualized: 19.7x

Last revenue growth (y/y): -2.6%

Last growth of EBITDA (y/y): -7.0%

Historical revenue growth: 9.1%

Historical growth of EBITDA: 15.2%

Target EV / EBITDA (hist percentile):

Fundamental value created in LTM:

EV / LTM EBITDA mutiple calculation

Market Cap ($m): 182 986

Net Debt ($m): 8 677

EV (Enterprise Value): 191 663

EBITDA LTM ($m): 9 481

EV / LTM EBITDA: 20.2x

Price to Book: 4.7x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News

2024-05-1124/7 Wall Street

JP Morgan Has 5 Blue Chip Passive Income Stocks as Top Picks for May

2024-05-09Reuters

Drugmaker Abbott India posts Q4 profit rise on higher sales

2024-05-08Finbold

Here's why you should buy these 3 stocks and hold them forever

2024-05-01InvestorPlace

Stock Market Crash Alert: 3 Must-Buy Healthcare Stocks When Prices Plunge

2024-05-01Zacks Investment Research

Is Trending Stock Abbott Laboratories (ABT) a Buy Now?

2024-04-30Zacks Investment Research

PBH vs. ABT: Which Stock Is the Better Value Option?

2024-04-22Zacks Investment Research

Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to Know

2024-04-22Forbes

Should You Pick Abbott Stock At $105 After An Upbeat Q1?

2024-04-17Investopedia

Abbott Labs Stock Falls as Q2 Guidance Outweighs Earnings Beat

2024-04-17Zacks Investment Research

Q1 Earnings Review

More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data

Enhanced Investments, Inc.
329 South Oyster Bay Road #2085
Plainview, NY 11803
team@eninvs.com

Important disclosures

Performance results were prepared by Enhanced Investments, and have not been compiled, reviewed or audited by an independent accountant. Performance estimates are subject to future adjustment and revision. Investors should be aware that a loss of investment is possible. Account holdings are for illustrative purposes only and are not investment recommendations. Additional information, including (i) the calculation methodology; and (ii) a list showing the contribution of each holding to the portfolio’s performance during the time period will be provided upon request.
All statements made via social media sites sponsored or maintained by Enhanced Investments and its affiliates are for informational purposes only and do not constitute a comprehensive description of Enhanced Investments' investment advisory services.
Certain investments are not suitable for all investors. Before investing, consider your investment objectives and applicable fees. The rate of return on investments can vary widely over time, especially for long term investments. Investment losses are possible, including the potential loss of all amounts invested. Information provided by Enhanced Investments is for informational and general educational purposes only and is not investment or financial advice.

Nothing on this website should be considered an offer, solicitation of an offer, or advice to buy or sell securities.
Past performance is no guarantee of future results. Any historical returns, expected returns [or probability projections] are hypothetical in nature and may not reflect actual future performance.
All the strategies assume investments in equity invstrumenta only and are more relevant for "agressive investment profile". Eastern European flagship strategy assumes using up to 20% leverage of total portfolio. GlobalCommodities and US Growth strategy currently assume no leverage.
Results for the Enhanced Investments strategies as compared to the performance of Illustrative Benchmarks is for informational purposes only. Our investment program does not mirror that of the Illustrative Benchmarks and the volatility may be materially different from the volatility of Illustrative Benchmarks. Reference or comparison to an Illustrative Benchmark does not imply that strategies of Enhanced Investments will be constructed in the same way as the Illustrative Benchmark or achieve returns, volatility, or other results similar to those of the Illustrative Benchmark. The S&P 500 is an unmanaged market capitalization-weighted index of 500 common stocks chosen for market size, liquidity, and industry group representation to represent U.S. equity performance.
Performance results were prepared by Enhanced Investments, and have not been compiled, reviewed or audited by an independent accountant. Performance estimates are subject to future adjustment and revision. Investors should be aware that a loss of investment is possible. Account holdings are for illustrative purposes only and are not investment recommendations. Additional information, including (i) the calculation methodology; and (ii) a list showing the contribution of each holding to the portfolio’s performance during the time period will be provided upon request.
All statements made via social media sites sponsored or maintained by Enhanced Investments and its affiliates are for informational purposes only and do not constitute a comprehensive description of Enhanced Investments' investment advisory services.
Certain investments are not suitable for all investors. Before investing, consider your investment objectives and applicable fees. The rate of return on investments can vary widely over time, especially for long term investments. Investment losses are possible, including the potential loss of all amounts invested. Information provided by Enhanced Investments is for informational and general educational purposes only and is not investment or financial advice.